Genotype – Phenotype Correlations and Timing of Prophylactic Thyroidectomy in Patients with Familial Medullary Thyroid Carcinoma Abstract #631

Introduction: Recommendations on the timing of prophylactic thyroidectomy (PTTE) in patients with familial medullary carcinoma (FMTC) are based on classification of RET mutations into four risk levels (ATA 2009).
Aim(s): To study the clinical course of FMTC patients with various RET mutations operated with a time delay against recommended timing.
Materials and methods: Retrospective analysis of clinical course in 42 RET mutation carriers from 12 FMTC and MEN 2A families.
Conference: 10th Annual ENETS Conference 2013 (2013)
Category: Non digestive NETs (bronchial, MTC, pheochromocytoma)
Presenting Author: prof. MD, PhD Jan Podoba

To read results and conclusion, please login ...

Further abstracts you may be interested in

#2000 A Case of Multiple Endocrine Neoplasia Type 2B(MEN2B)
Introduction: Familial neuroendocrine neoplasms (NENs) accounts for less than 5% of NENs and multiple endocrine neoplasia type 2B (MEN2B) is a kind of rare familial NENs.
Conference: 15th Annual ENETS conference 2018 (2018)
Category: Case reports
Presenting Author: Professor Jie Chen
Authors: Zhang Y, Chen L, Chen M, Chen J
#333 Sporadic Hypercalcitoninemia: Thyroid Medullary carcinoma, Autoimmune Thyroiditis or GLP-1 Agonists’ Effect?
Introduction: Glucagon-like peptide 1 (GLP-1) receptor agonists’ stimulated C-cell hyperplasia and tumors in rodents, but not in humans. Calcitonin also increased in autoimmune thyroid disease.
Conference: 8th Annual ENETS Conference (2011)
Category: Clinical
Presenting Author: Dr. Raluca A. Trifanescu
#1299 Clinical Value of Somatostatin Receptor Scintigraphy in the Management of Medullary Thyroid Carcinoma
Introduction: Medullary Thyroid Carcinoma (MTC) is a rare form of thyroid cancer. It represents 5 to 10 % of these cancers. MTC grows from specialized thyroid cells called para-follicular cells, or C-cells that secrete a hormone called calcitonin. Its prognosis is usually good. Recurrences can occur, requiring lifelong surveillance.
Conference: 13th Annual ENETS conference 2016 (2016)
Category: Imaging (radiology, nuclear medicine, endoscopy)
Presenting Author: Dorra Ben Sellem
#2201 Early Prognostic Factors in Medullary Thyroid Carcinoma
Introduction: Medullary thyroid carcinoma (MTC) prognosis has been related with several variables, being calcitonin doubling time one of the most important prognostic factor. However, it is not evaluable in the early postoperative period.
Conference: 15th Annual ENETS conference 2018 (2018)
Category: Endocrine malignancies (MTC, pheochromocytoma) - diagnosis and therapy
Presenting Author: Jose Luis Muñoz de Nova
#1266 Three Cases of Ectopic Adrenocorticotropic Hormone Syndrome Due to Medullary Thyroid Carcinoma
Introduction: Сushing's syndrome (CS) in medullar thyroid carcinoma (MTC) is rare. Among patients with MTC 0,7 % developed ectopic ACTH-syndrome (EAS). EAS due to MTS occurs in 2,2-8% of cases.
Conference: 13th Annual ENETS conference 2016 (2016)
Category: Pathology, grading, staging
Presenting Author: Iya Voronkova